Therapy News and Research

RSS

Intensive glucose control not better than standard treatment of hyperglycemia, study finds

Hyperglycemia, or high levels of glucose, is common in patients with acute ischemic stroke and is associated with worse outcomes compared to normal blood sugar levels.

24 Jul 2019

People experienced more cardiovascular events when unable to obtain their LDL-cholesterol drug

Individuals at high risk for cardiovascular events, including those with familial hypercholesterolemia or atherosclerotic heart disease experienced more heart attacks, strokes and other cardiovascular events when they were unable to obtain their prescribed LDL-cholesterol lowering medication.

24 Jul 2019

Clinical study demonstrates potential of regenerative therapy for hypoplastic left heart syndrome

A phase I clinical trial is the first research monitored by the Food and Drug Administration that demonstrates the potential of regenerative therapy for hypoplastic left heart syndrome through collecting, processing and injecting an infant's own stem cells directly into the heart at the time of surgery.

24 Jul 2019

Cognitive-behavioral therapy used to treat OCD can be successful for youth with hoarding symptoms

Hoarding can often be a debilitating problem for adults and is often associated with poorer mental health functioning and response to treatment.

24 Jul 2019

Giving antibiotics prior to liver transplant leads to better liver function

A UCLA-led research team has found that giving mice antibiotics for 10 days prior to a liver transplant leads to better liver function after the surgery.

23 Jul 2019

Connection to HIV treatment services helps gay, bisexual population to achieve viral suppression

Gay, bisexual and other men who have sex with men and transgender women with HIV, who are not in care, can be engaged in care when reached and connected with HIV treatment services, according to findings from a clinical trial supported by the National Institutes of Health.

23 Jul 2019

Retiring abroad? Prepare to possibly mix and match health insurance

When Karen Schirack, 67, slipped on her way into her house in January and broke her left femur in multiple places, she had a decision to make. Should she get surgery to repair the fractured thigh bone and replace her hip near Ajijic, Mexico, where she has lived for 20 years, or be airlifted back to her home state of Ohio for surgery and rehab?

23 Jul 2019

Obstructive sleep apnea may be one reason for treatment-resistant depression

When someone is depressed and having suicidal thoughts or their depression treatment just isn't working, their caregivers might want to check to see if they have obstructive sleep apnea, investigators say.

23 Jul 2019

Women with breast cancer should start postoperative chemotherapy soon

Women with breast cancer should start postoperative chemotherapy, when recommended, ideally within four months of their cancer diagnosis because new study findings show that waiting longer is associated with poorer overall survival.

23 Jul 2019

UTA scientists part of NIH-funded study of precision therapy for HFpEF patients

Nearly half of all heart failure patients do not have effective treatments for their condition, so three researchers at The University of Texas at Arlington are taking a more precise approach.

23 Jul 2019

Exosomes can restore health to brain cells affected by developmental disease

Like overpacked suitcases unloaded from the underbelly of a jet, molecular satchels called exosomes are continuously deployed from all cells in the body—each one brimming with an assortment of contents that another cell may unpack and use.

23 Jul 2019

Online pain and mood symptom self-management works better when coupled with clinician telecare

Pain is the most common physical symptom for which adults seek medical attention in the United States, while anxiety and depression are the most common mental health symptoms for which adults visit a doctor. Drugs, especially opioids, may not be the only or best therapy.

22 Jul 2019

UV-DDB protein scouts DNA damage and oversees repair

In the time it takes you to read this sentence, every cell in your body suffers some form of DNA damage. Without vigilant repair, cancer would run rampant, and now scientists at the University of Pittsburgh have gotten a glimpse of how one protein in particular keeps DNA damage in check.

22 Jul 2019

Study will investigate how to make talk therapy treatment more accessible to all women

Depression and anxiety during and after a pregnancy is the most common complication associated with having a child.

22 Jul 2019

FDA grants approval for generic versions of Lyrica

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury.

22 Jul 2019

Researchers identify encephalitis as rare toxicity of immunotherapy treatment

After a cancer patient receiving an immunotherapy developed encephalitis and died 18 months into treatment, researchers at Vanderbilt-Ingram Cancer Center investigated why the complication occurred, performing a molecular analysis of the disease's pathology and mining data to determine the incidence of similar occurrences.

22 Jul 2019

New technology helps develop more personalized treatments for patients with advanced cancers

Being able to identify targets for adoptive cell therapies is one of the first steps in developing personalized treatments for people with hard-to-treat cancers.

22 Jul 2019

How the Eastern Cherokee took control of their health care

Light pours through large windows and glass ceilings of the Cherokee Indian Hospital onto a fireplace, a waterfall and murals.

22 Jul 2019

BIA Separations selected to support AveXis’ gene therapy pipeline

BIA Separations, a leading biochromatography development and manufacturing company, today announced it is collaborating with AveXis, a Novartis company, to enhance the commercial purification process for its gene therapy pipeline, beginning with Zolgensma (onasemnogene abeparvovec-xioi), the first U.S. Food and Drug Administration-approved gene therapy indicated for the treatment of pediatric patients with spinal muscular atrophy (SMA) who are less than two years of age.

22 Jul 2019

ADHD impairs school readiness in preschoolers

Preschoolers with symptoms of attention-deficit hyperactivity disorder are much less likely than other children their age to be ready for school, new research from the Stanford University School of Medicine has found.

22 Jul 2019

Therapy News and Research

Intensive glucose control not better than standard treatment of hyperglycemia, study finds

People experienced more cardiovascular events when unable to obtain their LDL-cholesterol drug

Clinical study demonstrates potential of regenerative therapy for hypoplastic left heart syndrome

Cognitive-behavioral therapy used to treat OCD can be successful for youth with hoarding symptoms

Giving antibiotics prior to liver transplant leads to better liver function

Connection to HIV treatment services helps gay, bisexual population to achieve viral suppression

Retiring abroad? Prepare to possibly mix and match health insurance

Obstructive sleep apnea may be one reason for treatment-resistant depression

Women with breast cancer should start postoperative chemotherapy soon

UTA scientists part of NIH-funded study of precision therapy for HFpEF patients

Exosomes can restore health to brain cells affected by developmental disease

Online pain and mood symptom self-management works better when coupled with clinician telecare

UV-DDB protein scouts DNA damage and oversees repair

Study will investigate how to make talk therapy treatment more accessible to all women

FDA grants approval for generic versions of Lyrica

Researchers identify encephalitis as rare toxicity of immunotherapy treatment

New technology helps develop more personalized treatments for patients with advanced cancers

How the Eastern Cherokee took control of their health care

BIA Separations selected to support AveXis’ gene therapy pipeline

ADHD impairs school readiness in preschoolers

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News